Effects of low-dose oral contraceptive oestrogen and progestin on lipid peroxidation in rats. 1995

M A Sissan, and V P Menon, and S Leelamma
Department of Biochemistry, University of Kerala, India.

Groups of six female rats were treated with low-dose oral contraceptive (0.667 mg progestin [norethisterone acetate] and 0.02 mg oestrogen [ethinyloestradiol]/kg body-weight), or its components, separately, at the same doses, for 6 weeks. Changes in liver and kidney levels of lipid peroxides (as indicated by malondialdehyde production), free fatty acids, superoxide dismutase, and catalase liver glutathione and serum ceruloplasmin compared with the untreated control group were studied. Combined oral contraceptive treatment produced a significant increase in the activity of catalase in the kidneys (P < 0.05). The levels of lipid peroxides, free fatty acids and glutathione in the liver, and of serum ceruloplasmin increased significantly with oestrogen treatment (P < 0.05). Lipid peroxides (in the liver only), and serum ceruloplasmin decreased significantly when progestin was administered (P < 0.05). The activities of superoxide dismutase and catalase decreased significantly in the oestrogen group (except for catalase in the kidney) but increased in the progestin group (P < 0.05). The results indicate that the components of the low-dose oral contraceptive may alter liver and kidney metabolism.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D002570 Ceruloplasmin A multi-copper blood FERROXIDASE involved in iron and copper homeostasis and inflammation. Caeruloplasmin,Ferroxidase,Ceruloplasmin Ferroxidase,Ceruloplasmin Oxidase,Ferroxidase I,alpha(2)-Ceruloplasmin,Ferroxidase, Ceruloplasmin,Oxidase, Ceruloplasmin
D003277 Contraceptives, Oral, Combined Fixed drug combinations administered orally for contraceptive purposes. Combined Oral Contraceptive,Contraceptive Agents, Female, Combined,Oral Contraceptives, Combined,Combined Oral Contraceptives,Contraceptive, Combined Oral,Contraceptives, Combined Oral,Oral Contraceptive, Combined
D003278 Contraceptives, Oral, Hormonal Oral contraceptives which owe their effectiveness to hormonal preparations. Hormonal Oral Contraceptive,Hormonal Oral Contraceptive Agent,Contraceptive Agents, Estrogen,Contraceptive Agents, Oral, Hormonal,Hormonal Oral Contraceptive Agents,Oral Contraceptive Agents, Hormonal,Oral Contraceptives, Hormonal,Contraceptive, Hormonal Oral,Contraceptives, Hormonal Oral,Estrogen Contraceptive Agents,Hormonal Oral Contraceptives,Oral Contraceptive, Hormonal
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females

Related Publications

M A Sissan, and V P Menon, and S Leelamma
January 1987, Acta obstetricia et gynecologica Scandinavica,
M A Sissan, and V P Menon, and S Leelamma
January 2000, Acta poloniae pharmaceutica,
M A Sissan, and V P Menon, and S Leelamma
January 1974, Current medical research and opinion,
M A Sissan, and V P Menon, and S Leelamma
May 1971, American journal of obstetrics and gynecology,
M A Sissan, and V P Menon, and S Leelamma
June 1973, Acta Europaea fertilitatis,
M A Sissan, and V P Menon, and S Leelamma
January 2008, Clinical hemorheology and microcirculation,
M A Sissan, and V P Menon, and S Leelamma
January 1978, The Journal of international medical research,
M A Sissan, and V P Menon, and S Leelamma
December 1996, European journal of clinical investigation,
M A Sissan, and V P Menon, and S Leelamma
December 1990, International journal of epidemiology,
M A Sissan, and V P Menon, and S Leelamma
March 2004, British journal of clinical pharmacology,
Copied contents to your clipboard!